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Abstract
Modification of bacterial surface structures, such as the lipid A portion of lipopolysaccharide (LPS), is used by many
pathogenic bacteria to help evade the host innate immune response. Helicobacter pylori, a gram-negative bacterium
capable of chronic colonization of the human stomach, modifies its lipid A by removal of phosphate groups from the 1- and
49-positions of the lipid A backbone. In this study, we identify the enzyme responsible for dephosphorylation of the lipid A
49-phosphate group in H. pylori, Jhp1487 (LpxF). To ascertain the role these modifications play in the pathogenesis of H.
pylori, we created mutants in lpxE (1-phosphatase), lpxF (49-phosphatase) and a double lpxE/F mutant. Analysis of lipid A
isolated from lpxE and lpxF mutants revealed lipid A species with a 1 or 49-phosphate group, respectively while the double
lpxE/F mutant revealed a bis-phosphorylated lipid A. Mutants lacking lpxE, lpxF, or lpxE/F show a 16, 360 and 1020 fold
increase in sensitivity to the cationic antimicrobial peptide polymyxin B, respectively. Moreover, a similar loss of resistance is
seen against a variety of CAMPs found in the human body including LL37, b-defensin 2, and P-113. Using a fluorescent
derivative of polymyxin we demonstrate that, unlike wild type bacteria, polymyxin readily associates with the lpxE/F mutant.
Presumably, the increase in the negative charge of H. pylori LPS allows for binding of the peptide to the bacterial surface.
Interestingly, the action of LpxE and LpxF was shown to decrease recognition of Helicobacter LPS by the innate immune
receptor, Toll-like Receptor 4. Furthermore, lpxE/F mutants were unable to colonize the gastric mucosa of C57BL/6J and
C57BL/6J tlr4 -/- mice when compared to wild type H. pylori. Our results demonstrate that dephosphorylation of the lipid A
domain of H. pylori LPS by LpxE and LpxF is key to its ability to colonize a mammalian host.
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Introduction
Helicobacter pylori, a gram-negative bacterium with only one well-
defined niche, the human stomach, can persist for several years
without manifestation of symptoms. However, over time serious
complications may appear including peptic ulcer disease and
gastric cancer, allowing for classification of H. pylori as a class I
carcinogen by the World Health Organization [1,2]. Similar to
most gram-negative bacteria the outer membrane of H. pylori is
composed of lipopolysaccharide (LPS), a surface exposed glyco-
lipid.
LPS is anchored to the bacterial membrane by its hydrophobic
lipid A domain. Extended from lipid A is the core oligosaccharide
followed by the O-antigen creating a uniform hydrophilic surface
layer that interphases with the surrounding environment. The first
sugar of the core, Kdo (3-deoxy-D-manno-octulosonic acid), serves
as a bridge to link the lipid anchor to the carbohydrate domains of
LPS. The core polysaccharide is well conserved within a bacterial
species; however, this is not the case with O-antigen. H. pylori
shows great diversity in expression of its O-antigen [3], achieving a
form of molecular mimicry by assembling surface polysaccharides
resembling human blood group antigens, contributing to its ability
to evade immune detection [4].
The biosynthetic pathway for assembly of Kdo2-lipid A
(Figure 1), is well conserved throughout gram-negative bacteria
and proceeds via the nine-step enzymatic ‘‘Raetz pathway’’;
however, great variety is seen in Kdo2-lipid A structures when
comparing gram-negative bacterial species [5]. One of the best
examples of Kdo-lipid A diversity is the structure produced on the
surface of H. pylori (Figure 1). Variation in the Kdo-lipid A domain
of LPS is generated in part through the action of modification
enzymes [6]. The structural diversity among human pathogens
might have arisen through evolutionary pressures applied to the
bacterium by the host innate immune system.
To evade the host innate immune system by modification of its
lipid A, pathogenic bacteria employ several approaches. One
approach involves masking of negatively charged phosphate
groups present on the lipid A disaccharide backbone by adding
positively charged substituents, such as phosphoethanolamine or
L-4-aminoarabinose, while a second approach involves the
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complete removal of phosphate groups from the backbone [7].
Both approaches result in a net loss of negative surface charges,
resulting in a bacterial membrane more resistant to cationic
antimicrobial peptides (CAMPs). CAMPs are positively charged
peptides (e.g. defensins) that bind to negatively charged surface
structures (e.g. lipid A) present on the bacterial cell surface,
presumably creating pores in the membrane, resulting in cell lysis
and eventual death [8,9]. These structurally diverse CAMPs are
found in macrophages, neutrophils and at the mucosal surface,
making them an important component of the host innate immune
response [8]. It has also been reported that changes in lipid A
acylation or removal of Kdo (3-deoxy-D-manno-octulosonic acid)
core sugars, through the activity of modification machinery, play a
role in resistance to CAMPs [10,11].
The lipid A domain is responsible for the endotoxic properties
associated with LPS due to recognition and activation of the
human Toll-like receptor 4-myeloid differentiation factor 2
(hTLR4-MD2) complex [12]. The human Toll-like receptor 2
(hTLR2), known to recognize several conserved bacterial
structures including lipoteichoic acid and lipoproteins, has also
been shown to recognize atypical forms of LPS [13,14]. During
infection by gram-negative organisms, dissociated LPS is recog-
nized by the hTLR4-MD2 complex present on many cell types
[15]. In preventing dissemination of infection, LPS serves as a
molecular signal helping to clear the invading microbe; however,
over-stimulation of inflammatory mediators (e.g. TNF-a), can
result in the syndrome of septic shock [16]. LPS from enteric
bacteria such as Escherichia coli produce the typical highly
stimulatory lipid A (Figure 1), easily recognized by hTLR4-
MD2; however, many pathogenic bacteria produce altered lipid A
structures resulting in attenuated activation of hTLR4-MD2,
allowing for immune evasion [6]. Several tactics are employed to
produce hTLR4-MD2 attenuated lipid A structures, including the
incorporation of longer acyl chains (16 or 18 carbons) instead of
the standard (12 or 14 carbons) or by decreasing the overall
number of acyl-chains from hexa-acylated to penta- or tetra-
acylated lipid A forms [16]. In some organisms, the masking or
removal of phosphate groups on the disaccharide backbone serves
a dual role in CAMP resistance and attenuation of hTLR4-MD2
activation [17].
Figure 1. Chemical structures of the Kdo-lipid A domain of E. coli and H. pylori. The major lipid A species of E. coli is a hexa-acylated
disaccharide of glucosamine with phosphate groups at the 1- and 49-positions. The first sugar of the core oligosaccharide, Kdo (3-deoxy-D-manno-
octulosonic acid), is attached at the 69-position and serves as a bridge to link lipid A to the carbohydrate domains of LPS. The minor de novo lipid A
species of H. pylori is similar to that seen in E. coli, but has longer acyl chains. However, the mature surface exposed major lipid A species of H. pylori is
tetra-acylated that is lacking the 49-phosphate group, and is substituted at the C-1 position with a phosphoethanolamine residue. Phosphate groups




Since its discovery in 1982 Helicobacter pylori has been
identified as the leading cause of gastritis and peptic ulcer
disease, infecting around 50% of the world’s population.
Infected patients are at increased risk for gastric cancers,
allowing for classification of H. pylori as a class I carcinogen
by the World Health Organization. H. pylori has only one
well defined niche, the human stomach. Since no other
reservoirs exist, a unique balance must be established
during infection permitting long-term survival of both the
bacterium and its human host. Here, we show that H. pylori
modifies its primary surface component, lipopolysaccha-
ride (LPS), making the bacterium undetectable by compo-
nents of the innate immune system and highly resistant to
antimicrobial compounds secreted by host cells. Mutant
strains of H. pylori unable to modify their surface show
increased sensitivity to antimicrobial peptides (,1000 fold)
and increased recognition by components of the innate
immune system. H. pylori mutants were unable to colonize
mouse models, suggesting that remodeling of LPS is
essential for survival within the gastric mucosa. Under-
standing the adaptations used by H. pylori to survive and
persist within the human host is key towards unraveling
how this unique organism impacts gastric disease.
H. pylori LPS Remodeling
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H. pylori produce a minimal Kdo-lipid A structure that is tetra-
acylated with a phosphoethanolamine residue attached at the 1
position of the disaccharide (Figure 1), presumably contributing to
high CAMP resistance and attenuated hTLR4-MD2 activation
reported for this pathogen [18]. Since no other reservoirs exist for
H. pylori, a unique balance must be established during infection in
order to permit long-term survival of both the bacterium and its
human host. Unlike a number of bacterial pathogens [6],
modification of H. pylori lipid A appears to be constitutive and is
not regulated by specific environmental cues [19]. Furthermore,
the H. pylori lipid A modification pathway is highly ordered and
efficient giving rise to a single lipid A species. This is in contrast to
the lipid A variation seen on the surface of other pathogens [19].
Given that only one known reservoir exists for H. pylori, the human
stomach, adaptation to changing environmental conditions is
presumably unnecessary and explains this lack of regulation and
single form of lipid A.
De novo lipid A synthesized by H. pylori is modified from a bis-
phosphorylated hexa-acylated Kdo2-lipid A structure (Figure 1)
by a five-step enzymatic pathway (Figure 2) and a single distinct
lipid A species is produced [19,20,21,22]. Previous studies from
our laboratory have characterized the enzymes responsible for
four of these steps; however, the identity of the lipid A 49-
phosphatase in H. pylori has yet to be identified or character-
ized. Thus, what role the 49-phosphatase plays in CAMP
resistance or in modulation of hTLR4-MD2 activation has not
been addressed. Furthermore, although the lipid A 1-phospha-
tase (LpxE) of H. pylori was shown to be important for CAMP
resistance, its role in hTLR4-MD2 activation remains unclear
[17]. Here we report the identification of the lipid A 49-
phosphatase in H. pylori and demonstrate that the 1 and 49-
phosphatases act synergistically to produce a bacterial surface
that is highly resistant to CAMP attack. We also show that
dephosphorylation of H. pylori lipid A at the 1 and/or 49
position results in LPS with attenuated hTLR4-MD2 activation.
Most exciting, our results suggest that modification of H. pylori
lipid A phosphate groups are important for colonization of a
host.
Figure 2. Modification pathway of H. pylori Kdo-lipid A. H. pylori produce a highly modified lipid A species via a five step enzymatic pathway.
First, the 1-phosphate group is cleaved by LpxE (Jhp0019) followed by the addition of phosphoethanolamine by EptA (Jhp0020) at the 1-position.
Phosphatidylethanolamine (PE) likely serves as the donor for EptA resulting in the formation of diacylglycerol (DAG). Next KdoH1 (Jhp0526) and
KdoH2 (Jhp0527) act in concert to remove the terminal Kdo sugar. The 49-phosphate group is removed by LpxF (Jhp1487) leaving an unmodified
hydroxyl group, followed by removal of the 39-O-linked acyl chains by LpxR (Jhp0634) resulting in a tetra-acylated lipid A. Following transport of core-
lipid A across the inner membrane, the first four modification reactions occur at the periplasmic face of the inner membrane. The final step, catalyzed
by LpxR, occurs in the outer membrane to produce H. pylori Kdo-lipid A (inset). Cartoon structures are shown to illustrate the intermediate structures
in the pathway. The phosphate groups are shown in red, Kdo shown in green, and phosphoethanolamine in magenta. The core-oligosaccharide and
O-antigen are not shown for simplicity.
doi:10.1371/journal.ppat.1002454.g002
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Results
The H. pylori Lipid A 49-Phosphatase Is Encoded by
jhp1487
The published structure for wild type H. pylori is Kdo-lipid A
that is tetra-acylated with a phosphoethanolamine attached at the
1-position (Figure 1) [18]. Previous work in our laboratory
identified and characterized the Kdo2-lipid A modification
machinery in H. pylori, including LpxE (1-phosphatase), EptA
(phosphoethanolamine transferase), KdoH1/2 (Kdo Hydrolase)
and LpxR (39-O-deacylase), which all act in an ordered efficient
manner to produce a single lipid A species found on the bacterial
surface (Figure 2) [19,20,22]. To date, all enzymes have been
identified and characterized except for the enzyme responsible for
removal of the lipid A 49-phosphate group, also known as LpxF
(49-phosphatase).
Previous attempts to identify H. pylori lpxF by our laboratory
have proven unsuccessful, as heterologous expression of possible
homologs in E. coli have failed to demonstrate LpxF activity in
whole cells [17]. Searching the H. pylori genome for proteins
homologous to LpxE (Hp0021) using the Blastp algorithm [23]
revealed three possibilities, identified as belonging to a family of
phosphatidic acid type 2 phosphatases (PAP2), Jhp0324, Jhp0787
and Jhp1487. Along with LpxE these proteins are members of
COG0671, a cluster of putative orthologs of E. coli PgpB. PgpB is a
membrane-bound phosphatidylglycerol phosphatase involved in
phospholipid biosynthesis. A ClustalW2 alignment of Jhp0324,
Jhp0787 and Jhp1487 against LpxE revealed a score of 8%, 7%
and 20%, respectively. Score is defined as percent identities
divided by number of residues compared. Given that Jhp1487
showed the highest score (20%) when aligned with LpxE, it
became the likely target. A knockout in jhp1487 was created by
interruption of the coding sequence with an antibiotic resistance
cassette in H. pylori strain J99 and named J99 lpxF. Complemen-
tation of J99 lpxF was achieved by re-introduction of lpxF into the
chromosome and named J99 lpxF, lpxF+.
To screen for LpxF activity in membrane fractions, in vitro assays
were performed using radiolabelled Kdo2-[49
32P]lipid A as the
substrate (Figure 3). Following incubation of the enzyme source
with the radioactive substrate, the reaction products were
separated via thin-layer chromatography (TLC) such that the
more hydrophobic reaction products migrated faster. As expected,
wild type H. pylori J99 membranes show robust LpxF activity (lane
2) as indicated by the appearance of free inorganic phosphate
(32Pi), while membranes isolated from J99 lpxF were completely
free of 49-phosphatase activity (lane 3). LpxF activity was restored
in membranes isolated from the complemented strain J99 lpxF,
lpxF+ (lane 4), indicating that the H. pylori lipid A 49-phosphatase is
encoded by jhp1487. Reaction products from the previously
characterized 1-phosphatase (LpxE) [20] and Kdo hydrolase
(KdoH1/H2) [19,21] were also detected. Loss of jhp1487 had no
effect on 1-phosphatase or Kdo hydrolase activity. It was
demonstrated previously [17] that membranes lacking a functional
LpxE were unable to catalyze removal of the 1-phosphate group of
lipid A substrates. Thus, ruling out H. pylori LpxF as a lipid A 1-
phosphatase.
Characterization of Lipid A from Select H. pylori Mutants
To clearly ascertain the role LpxE and LpxF play in the
pathogenesis of H. pylori, a series of mutants were generated,
including a single lpxE, lpxF and a double lpxE/F mutant. Single
lpxE and double lpxE/F mutants were created by introduction of a
previously described lpxE mutation [17] into wild type J99 and J99
lpxF background by natural transformation, creating J99 lpxE and
J99 lpxE/F, respectively. Complementation of J99 lpxE was
achieved by re-introduction of lpxE into the chromosome and
named J99 lpxE, lpxE+. Additionally, all mutations were moved
into the mouse adapted H. pylori strains, B128 and X47 [24,25,26].
To thoroughly characterize this series of mutants, the lipid A
species produced by each strain was determined. To begin, all
strains were grown in the presence of 32Pi, the lipid A purified,
separated by TLC and visualized by phosphorimaging. H. pylori
wild type strains J99, B128 and X47 all revealed a single identical
species of lipid A indicating no variation between backgrounds
(Figure 4A). In contrast, lipid A from the single lpxE, lpxF and
double lpxE/F mutants showed differences in migration compared
to that of wild type. Chromosomal complementation of either the
lpxE or lpxF mutations resulted in production of wild type lipid A
(Figure 4B).
To confirm changes in lipid A and determine the structure, lipid
A from all strains was subjected to analysis by MALDI-TOF
(matrix-assisted laser desorption/ionization-time of flight) mass
spectrometry in the negative ion mode. The wild type J99
spectrum showed a predominant peak at m/z 1546.9 consistent
with the [M–H]- ion of the wild type structure of H. pylori lipid A
(predicted [M–H]- at m/z 1547.1), which is tetra-acylated without
a phosphate group at the 49-position and a phosphoethanolamine
residue at the 1-position (Figure 5). The lpxF mutant spectrum
showed a predominant peak at m/z 2091.0 consistent with the
[M–H]- ion of a lipid A species that is hexa-acylated with a
phosphate group at the 49-position and a phosphoethanolamine
residue at the 1-position (predicted [M–H]- at m/z 2091.5),
confirmation that the H. pylori LpxF is encoded by jhp1487. The
presence of hexa-acylated lipid A species in the lpxF mutant
suggest an ordered modification system in which H. pylori LpxR
(39-O-deacylase) activity is dependent on removal of the lipid A 49-
phosphate group by LpxF. The lpxE mutant spectrum (Figure 5)
showed a predominant peak at m/z 1504.8 consistent with the
[M–H]- ion of a lipid A species that is tetra-acylated bearing a
single phosphate group (predicted [M–H]- at m/z 1505.1), in
agreement with the published lipid A structure of lpxE deficient H.
pylori strains [17]. The double lpxE/F mutant spectrum showed a
predominant peak at m/z 2048.2 consistent with the [M–H]- ion
of a lipid A species that is hexa-acylated with a phosphate group at
the 1- and 49-positions (predicted [M–H]- at m/z 2048.5) (Figure 5).
Complemented lpxE and lpxF strains showed a predominate peak
consistent with that of wild type H. pylori (Figure 5). Moreover,
MALDI-TOF mass spectrometry analysis of lipid A purified from
all mutants in B128 (Figure S1 in Text S1) and X47 (Figure S2 in
Text S1) backgrounds, agreed with corresponding J99 stains. The
proposed structure for the lipid A species found in each strain is
illustrated in Figure 5.
Dephosphorylation of Lipid A by LpxE and LpxF Results
in Resistance to CAMPs
Resistance to CAMPs is of great importance to all mucosal
pathogens. This is especially true for H. pylori whose only known
reservoir is the human gastric mucosal surface. H. pylori is highly
resistant to the CAMP polymyxin B (PMB) with the minimal
inhibitory concentration (MIC) of wild type strains ranging from
250–1000 mg/ml peptide [19]. PMB is an experimental substitute
for CAMPs and commonly used to demonstrate CAMP resistance
in laboratory settings because of a similar mechanism of action
[27]. MICs were determined for all strains using PMB Etest strips.
H. pylori wild type strain J99 and all complemented strains
exhibited a PMB MIC (469.3673.9 mg/ml) comparable to
published determinations [17,19]. The lpxE, lpxF and double
lpxE/F mutants in background J99 showed a 16, 360 and 1020
H. pylori LPS Remodeling
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fold decrease in resistance to PMB, with MICs of 29.364.6,
1.360.3 and 0.4660.03 mg/ml, respectively (Table 1). Thus,
although LpxE and LpxF work in concert to produce a highly
resistance bacterial membrane, removal of the 49-phosphate group
has the most influence on CAMP resistance in H. pylori.
To rule out changes in acylation in the single lpxF and double
lpxE/F mutant as playing a role in CAMP resistance, the MIC of a
previously characterized lpxR mutant was also determined and
found to be comparable (51260.0 mg/ml) to that shown by wild
type H. pylori (Table 1). The lipid A of the lpxR deficient strain is
hexa-acylated without a phosphate group at the 49-position and a
phosphoethanolamine residue at the 1-position [22] suggesting
that, in H. pylori, deacylation plays no role in resistance to CAMPs.
MICs were also determined for mutants in the mouse adapted
Figure 3. In vitro assay of the H. pylori lipid A 49-phosphatase, LpxF. Membranes from an lpxF deficient mutant in strain J99 were assayed
using Kdo2-[49-
32P]lipid A as the substrate. LpxF activity is indicated by the appearance of free radiolabeled inorganic phosphate (32Pi). The LpxF
mutant showed a complete loss of 49-phosphatase activity, which was fully restored in the complemented strain. Reaction products from the
previously characterized 1-phosphatase (LpxE) [20] and Kdo hydrolase (KdoH1/H2) [19,21] were also detected. Cartoon structures are shown to
illustrate reaction products. The 1-phosphate group is shown in black, the radiolabeled 49-phosphate group in red, and the Kdo sugars are shown in
green.
doi:10.1371/journal.ppat.1002454.g003
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backgrounds, B128 and X47, and were found to be comparable to
J99 stains (Table 1).
The lifecycle and transmission of H. pylori is not well understood.
Most literature agrees that oral familial passage of the bacterium is
the most likely route of transmission, suggesting that H. pylori must
not only resist CAMPs located at the gastric mucosal surface, but
also those found in the oral cavity [28]. Moreover, the bacterium
must resist CAMPs secreted by a variety of leukocytes, constantly
surveying for invading pathogens [8]. To confirm our PMB MIC
findings, we repeated MIC determinations using CAMPs possibly
encountered by H. pylori during its lifecycle. We chose a number of
peptides relevant to human infection for this study including: (i) the
human cathelicidin LL-37 produced by both leukocytes and
epithelial cells, (ii) human b-defensin 2 (HBD-2) found throughout
the gastrointestinal tract, (iii) P-113, a fragment of histatin 5 found
within the oral cavity, (iv) and HNP-2, an a–defensin produced by
neutrophils [9,29].
To determine the MICs, a standard microtiter broth dilution
method was utilized. J99 wild type was highly resistant to all
CAMPs analyzed (Table 2). The lpxE, lpxF and double lpxE/F
mutants all showed a decrease in resistance against LL37, P-113,
and HBD-2, similar to what is seen against PMB (Table 2). Once
again, LpxF activity seemed to have the largest influence on
resistant CAMPs. No change in resistance was seen for the a–
defensin HNP2 at the indicated concentrations (Table 2). The lpxR
deficient strain was identical to that of wild type, once again
Figure 4. TLC analysis of 32P-labelled lipid A from select H. pylori strains. H. pylori were grown in the presence of 32Pi, the lipid A purified,
separated by TLC and visualized by phosphorimaging. (A) All strains of wild type H. pylori (J99, B128, and X47) revealed identical lipid A species. (B)
TLC analysis of wild type J99 and complemented strains revealed a single lipid A species with migration typical of wild type H. pylori lipid A. Analysis
of the lpxE, lpxF, and double lpxE/F mutants in a J99 background reveal changes in the migration pattern, indicating changes in the lipid A structure.
The structure of each lipid A species was later identified by MALDI-TOF mass spectrometry analysis and cartoon structures are included for
clarification. Phosphate groups are shown in red and phosphoethanolamine is shown in magenta. A minor penta-acylated lipid A species indicated
by an asterisk was present in lpxF deficient backgrounds.
doi:10.1371/journal.ppat.1002454.g004
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Figure 5. Mass spectrometry of lpxE, lpxF and lpxE/F mutants in strain J99. Lipid A was isolated from wild type, lpxE, lpxF, lpxE/F and
complemented strains in strain J99 and analyzed by MALDI-TOF mass spectrometry in the negative-ion mode. Wild type and complemented stains
produced a peak at 1546.9 to 1547.8 m/z corresponding to the published wild type H. pylori lipid A structure [20,59]. The lpxE, lpxF and lpxE/F
mutants showed a peak at m/z 1504.8, 2091.0 and 2048.2, respectively. 1504.8 corresponds to tetra-acylated 1-phosphorylated lipid A, 2091.0 to
hexa-acylated 49-phosphorylated lipid A and 2048.2 to hexa-acylated bis-phosphorylated lipid A. The lipid A structure for each strain is shown with
changes to phosphate groups outlined in red and changes in acylation outlined in blue.
doi:10.1371/journal.ppat.1002454.g005
Table 1. Minimal Inhibitory Concentrations (MIC) of polymyxin against H. pylori strains.
H. pylori strain
Background J99





Wild Type 469.3673.9 213.3637.0 768.060.0
lpxF 1.360.3 1.860.3 2.360.6
lpxF, lpxF + 512.060.0 213.3637.0 682.76147.8
lpxE 29.364.6 26.764.6 37.369.2
lpxE, lpxE + 469.3673.9 234.7637.0 768.060.0
lpxE/F 0.4660.03 0.6160.04 0.5560.08
lpxR 512.060.0 ND ND
lpxR, lpxR + 469.3673.9 ND ND
MIC are reported as mg/ml and are the average of three experiments using Polymyxin B E-Test strips (Biomerieux) on TSA supplemented with 5% blood. ND = Not
determined.
doi:10.1371/journal.ppat.1002454.t001
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confirming that deacylation of LPS plays no role in resistance to
CAMPs in H. pylori (Table 2). Together, these results indicate that
dephosphorylation of lipid A in H. pylori, by LpxE and LpxF, is
essential for resistance to CAMPs.
Interestingly, H. pylori produces an antibacterial peptide referred
to as Hp (2.20), related to the insect cecropins that bind to the
phosphate groups of lipid A [30]. H. pylori is naturally resistant to
Hp (2.20), and it has been suggested that release of this peptide
into the stomach may contribute to clearance of other gastroin-
testinal pathogens providing some benefit to H. pylori infected
individuals [30]. Again, the double lpxE/F mutant shows a large
decrease ($ 60 fold) in resistance against Hp (2.20) (Table 2). The
level of Hp (2.20) production by Helicobacter during colonization of
the gastric mucosa is unclear; however, it is likely that modification
of the lipid A structure provides protection against this Helicobacter
derived antimicrobial compound.
Dephosphorylation of Lipid A by LpxE and LpxF Produce
a Surface More Resistant to CAMP Binding
CAMPs primary mode of action against bacteria is to bind
negatively charged moieties present on the bacterial surface (e.g.
phosphate groups) [8]. Unlike most gram-negative bacteria, wild
type strains of H. pylori completely lack unsubstituted phosphate
moieties on its LPS [18]. However, LpxE/F deficient H. pylori
strains produce an LPS anchored to the membrane by bis-
phosphorylated lipid A (Figure 5) providing a negatively charged
target for positively charged CAMPs.
To visually assess this, we devised a PMB binding assay by use
of a biologically active fluorescent Oregon Green 514 derivative of
polymyxin B (PMB-OG). Briefly, H. pylori wild type and double
lpxE/F mutant in strain J99 were incubated for 10 minutes in the
presence of 0, 1, 25, or 250 mg/ml PMB-OG and visualized by
phase contrast and fluorescence microscopy (Figure 6). Overlay
images clearly illustrate that unlike wild type, the double lpxE/F
mutant fluoresced when incubated with 1 mg/ml PMB-OG,
indicating increased surface-bound or entry of PMB-OG. Even
at 25 mg/ml of peptide, essentially no fluorescence was observed
for wild type bacteria. Both strains fluoresced when incubated with
250 mg/ml PMB-OG, although wild type was lower in intensity.
These images visually demonstrate the protective effect lipid A
dephosphorylation by LpxE and LpxF has against CAMP attack
of the bacterial surface of H. pylori.
To quantify the binding and/or entry of PMB-OG to H. pylori
strains, stained cells were re-suspended in PBS and fluorescent
intensity measured (Figure S3 in Text S1). The double lpxE/F
mutant showed significantly increased fluorescence when compared
to wild type confirming our visual interpretation of the fluorescence
microscopy. Furthermore, quantitative fluorescent analysis of PMB-
OG binding to the lpxE, lpxF, lpxR and complemented mutants
corresponded to the loss of CAMP resistance seen in our MIC
experiments (Table 2) solidifying these findings.
Dephosphorylation of Lipid A by LpxE and LpxF Results
in Attenuated TLR4-MD2 Activation and Has No Effect on
TLR2 Activation
H. pylori LPS is characterized by strikingly low endotoxicity
which may contribute to the long-term carriage state of the
organism [18]. LPS from F. tularensis and P. gingivalis also exhibit
very low endotoxicity and both organisms harbor lipid A
phosphatases [31,32]. LPS purified from LpxF deficient F. tularensis
mutants which produce a penta-acylated form of lipid A failed to
show increases in hTLR4-MD2 activation, indicating no role in
attenuation [31]. However, given that hTLR4-MD2 is unable to
recognize LPS anchored to the membrane by a penta-acylated
form of lipid A, this result is not surprising [33]. Alternatively, LPS
purified from LpxE and/or LpxF deficient P. gingivalis, triggered
an increased hTLR4-MD2 response, indicating lipid A dephos-
phorylation plays a role in its low endotoxicity [32]. The ability of
LPS from a number of bacteria to elicit an immune response has
been examined. However, much of the literature describes
experiments using LPS isolated from bacteria (e.g. P. gingivalis)
producing a mixture of lipid A species, complicating the findings
[34]. Further confusing the literature are reports that heavily
modified forms of lipid A, like that found in H. pylori, P. gingivalis,
and Leptospira interrogans elicit an immune response through hTLR2
[14,35,36,37,38]. Fortuitously, H. pylori and the mutants generated
herein produce an abundant single species of lipid A (Figures 4 &
5), giving us the ability to investigate the contribution of single lipid
A modification in hTLR4-MD2 and hTLR2 activation.
The Toll-activation profiles of intact LPS were examined using
samples purified using by the Hirschfield method [39] that allows
for removal of potential contaminating lipoproteins. Activation of
TLRs was monitored using HEK-Blue 293 cells stably transfected
with TLR machinery and a secreted alkaline phosphatase (SEAP)
reporter gene placed under the control of an NF-kB inducible
promoter allowing for easy detection of TLR activation using a
colorimetric assay. Changes in hTLR4-MD2 activation in the H.
pylori strains are clearly illustrated in Figure 7A. LPS from the H.
pylori single lpxE, lpxF and double lpxE/F mutant show 2, 6 and 10
fold significant (P #0.001) increases in activation of hTLR4-MD2
at 10000 ng/ml when compared to wild type, indicating that LpxF
imparts greater influence on attenuated hTLR4-MD2 when
compared to LpxE. This agrees with the published crystal
structure of the hTLR4-MD2-LPS complex showing that the 49
phosphate group is involved for ligand recognition [40]. Similar
results were seen using 1000 ng/ml of LPS (Figure 7A). LPS
Table 2. Minimal Inhibitory Concentrations (MIC) of cationic antimicrobial peptides against H. pylori strains.
Strain Polymyxin HP2.201 HNP2 (a-Def)2 HBD2 (b-Def)3 LL374 P1135
J99 Wild Type .250 .1250 .25 .25 40 6 5 .400
J99 lpxE 22 6 2 583 6 29 .25 23 6 3 40 6 0 341 6 14
J99 lpxF 3.8 6 0.3 60 6 0 .25 12 6 1 19 6 2 178 6 3
J99 lpxE/F 0.6 6 0.1 18 6 3 .25 5.0 6 1.0 11 6 1 141 6 14
J99 lpxR .250 .1250 .25 .25 41 6 6 .400
MIC are reported as mg/ml and are the average of three experiments.
1Helicobacter pylori (2–20); 2 human neutrophil peptide-2 (a-defensin);
3human beta defensin-2 (b-defensin); 4 human cathelicidin LL-37; 5 P-113 fragment of histatin-5.
doi:10.1371/journal.ppat.1002454.t002
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isolated from the lpxR deficient mutant activated hTLR4-MD2
similar to wild type LPS indicating that lipid A dephosphorylation
plays a larger role in lowering endotoxicity compared to
deacylation of Helicobacter lipid A (Figure 7A). Although these
findings are of interest, it is important to note that in comparison
to E. coli LPS, higher concentrations of Helicobacter LPS are
required for activation of TLR4. For each experiment LPS from
R. sphaeroides (1000 ng/ml), a known TLR4 antagonist [41], and E.
coli (10 and 1000 ng/ml) were used as a negative and positive
controls for activation of hTLR4-MD2, respectively (Figure 7B).
Figure 6. Fluorescent polymyxin B whole cell binding assay. H. pylori wild type J99 and the double lpxE/F mutant were incubated for 10
minutes in the presence of Oregon Green 514 polymyxin B (PMB-OG) at the indicated concentrations. Bacteria were visualized by phase contrast and
fluorescence microscopy (shown as overlays, 1000X). Unlike wild type, the double lpxE/F mutant fluoresced when incubated with 1 or 25 mg/ml PMB-
OG, suggesting increased ability to bind CAMPs. Both strains fluoresced when incubated with 250 mg/ml, although wild type fluorescence was lower
in intensity. See Figure S3 in Text S1 for quantitative measure of this data.
doi:10.1371/journal.ppat.1002454.g006
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LPS from the H. pylori single lpxE, lpxF and double lpxE/F
mutants showed no significant activation of hTLR2 (p.0.05),
even at LPS concentrations as high as 10,000 ng/ml when
compared to wild type LPS (Figure 8A). LPS from E. coli
(1000 ng/ml) and Pam3CSK4 (10 and 1000 ng/ml), a synthetic
lipopeptide, were used as a negative and positive control for
activation of hTLR2, respectively (Figure 8B). H. pylori LPS has
been reported to act as both a hTLR4-MD2 and hTLR2 agonist
[42]; however, the ability of H. pylori LPS to activate hTLR2 is
more controversial. Our data suggest that H. pylori LPS does not
activate hTLR2. Some of these discrepancies may arise because of
contaminating lipoproteins in LPS preparations. Recent literature
documenting activation of hTLR2 by H. pylori LPS used
concentrations as high as 10,000 ng/ml [42], increasing the
possibility that activation was not the result of LPS but rather
contamination. All TLR activation studies were performed using
LPS purified from strains in background J99.
Previous research has demonstrated that hTLR4-MD2 and
murine TLR4-MD2 (mTLR4-MD2) display differential recogni-
tion of LPS [33]. In anticipation of a future colonization study
using a murine host, we felt it necessary to address this by
examining the ability of H. pylori LPS to activate mTLR4-MD2.
Activation of TLRs was monitored using HEK-Blue 293 cells
stably transfected with murine TLR machinery using the same
Figure 7. Activation of human or murine TLR4-MD2 by H. pylori LPS. Activation of TLR4 was monitored using HEK-293 cells stably transfected
with either human TLR4-MD2-CD14 or murine TLR4-MD2-CD14. TLR activation was monitored colorimetrically using a secreted alkaline phosphatase
(SEAP) reporter gene placed under the control of an NF-kB inducible promoter. Highly purified LPS from the indicated strains of H. pylori was added
to each well in triplicate at 0, 10, 100, 1000 and 10000 ng/ml. Values are the mean of results from triplicate wells 6 standard deviation. When
compared to wild type, LPS (10000 ng/ml) from the lpxE, lpxF, and lpxE/F mutants showed an ,2, 6 and 10-fold significant increase in hTLR4-MD2
activation, respectively. hTLR4-MD2 acitvation by LPS prepared from the LpxR mutant and complemented strains were identical to that of wild type
(p.0.05). Where appropriate, an asterisk was used to indicate significance (p #0.001) (A). For experiments with hTLR4-MD2, LPS from R. sphaeroides
(1000 ng/ml) and E. coli (10 and 1000 ng/ml) was used as negative and positive controls for activation of hTLR4-MD2, respectively (B). When
compared to wild type, LPS (10000 ng/ml) from the lpxE, lpxF, lpxR and lpxE/F mutants showed an ,10, 8, 9 and 5 fold significant increase in mTLR4-
MD2 activation, respectively. mTLR4-MD2 acitvation by LPS prepared from complemented strains were identical to that of wild type (p.0.05). Where
appropriate, an asterisk was used to indicate significance (P #0.01) (C). For experiments with mTLR4-MD2, endotoxin free water and LPS purified from
E. coli (10 and 1000 ng/ml) was used as negative and positive controls for activation of mTLR4-MD2, respectively (D). LPS from R. sphaeroides is a
known mTLR4-MD2 agonist and was not used as a negative control. All results agreed between experimental and biological replicates. Cells were
stimulated for 24 hours with the indicated ligands.
doi:10.1371/journal.ppat.1002454.g007
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reporter system described above. Changes in mTLR4-MD2
activation in the H. pylori strains are clearly illustrated in
Figure 7C. LPS from the H. pylori single lpxE, lpxF, lpxR and
double lpxE/F mutant show 10, 8, 9 and 5 fold significant (p
#0.001) increases in activation of mTLR4-MD2 at 10000 ng/ml
when compared to wild type (Figure 7B), suggesting that LpxE,
LpxF and LpxR all play similar roles in mTLR4-MD2 ligand
recognition and confirming species-specific differential recognition
of LPS. Differential recognition by mTLR4-MD2 of LPS purified
from an lpxR deficient background is not surprising considering the
promiscuity of this receptor for lipid A isoforms (i.e. tetra- and
penta-acylated lipid A) [33]. For each experiment endotoxin free
water and E. coli (10 and 1000 ng/ml) were used as negative and
positive controls for activation of mTLR4-MD2, respectively
(Figure 7D). LPS from the H. pylori single lpxE, lpxF, lpxR and
double lpxE/F mutants showed no significant activation of
mTLR2 (p.0.05), even at LPS concentrations as high as
10,000 ng/ml when compared to wild type LPS (data not shown).
Dephosphorylation of Lipid A by LpxF Is Required for
Host Colonization in H. pylori
To date, nothing is known regarding participation of H. pylori
LPS modifications in host colonization. Presumably, dephosphor-
ylation by LpxE and LpxF provides an advantage through
resistance to CAMPs at the gastric mucosal surface and attenuated
hTLR-MD2 activation. Francisella mutants lacking lpxF were
greatly attenuated in animal studies and considered avirulent
[31]. However, F. tularemia does not establish a long-term
colonization of its human host but rather, results in quick
progression to severe illness and/or death [43]. Considering our
current findings, we felt it was important to proceed with an in vivo
animal study to emphasize the role played by LpxE and LpxF in
host colonization.
For these experiments, all mutations were transferred into the
mouse-adapted strains B128 and X47 [24]. Two bacterial strains
were used to rule out the influence of variation between strains and
for confirmation of findings. Recent publications in Campylobacter
jejuni and H. pylori have demonstrated that lipid A modification
enzymes can modulate motility and O-antigen expression,
respectively [19,44]. Both of these have been shown to be
important for host colonization. Given these findings, we felt it
important to examine both phenotypes prior to colonization
studies. The LPS profiles (O-antigen polysaccharide and core
oligosaccharide composition) of all mutants were indistinguishable
from that of wild type during SDS-PAGE (Figure S4 in Text S1)
and all strains showed normal motility in a soft agar assay (Figure
S5 in Text S1), suggesting LpxE and LpxF do not influence these
phenotypes. Mutants in H. pylori background J99 were used to
illustrate these findings. However, identical results were found in
both mouse-adapted strains, B128 and X47 (data not shown).
Two mice populations, C57BL/6J and C57BL/6J tlr4-/-, were
colonized. The TLR4 deficient mice were used in conjunction
with wild type mice to help determine which plays a larger role in
host colonization: CAMP resistance or attenuated hTLR4-MD2
activation. Mice were infected orogastrically with 26108 bacteria
per mouse. Colonization rates were determined by enumeration of
colony forming units per gram (CFU/g) of stomach. Two
independent colonization experiments were performed. The first
was a 15-day time point using both B128 and X47 strains in
C57BL/6J. The second was a time course colonization experiment
Figure 8. Activation of hTLR2 by H. pylori LPS. Activation of hTLR2 was monitored using HEK-293 cells stably transfected with hTLR2. TLR
activation was monitored colorimetrically using a secreted alkaline phosphatase (SEAP) reporter gene placed under the control of an NF-kB inducible
promoter. Cells were stimulated for 24 hours with the indicated ligands. Highly purified LPS from the indicated strains of H. pylori was added to each
well in triplicate at 0, 10, 100, 1000 and 10,000 ng/ml. Values are the means of results from triplicate wells 6 standard deviation. No significant
activation of hTLR2 was seen in LPS prepared from the lpxE, lpxF, and lpxE/F mutants when compared to wild type H. pylori J99 (P.0.05) (A). The
results agreed between experimental and biological replicates. For each experiment LPS from E. coli (1000 ng/ml) and Pam3CSK4 (10 and 1000 ng/
ml), a synthetic lipopeptide, were used as negative and positive controls for activation of hTLR2 (B), respectively. Identical results were seen for
activation of mTLR2 (data not shown).
doi:10.1371/journal.ppat.1002454.g008
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at days 3, 15, and 45 using only strain B128 in both C57BL/6J
and C57BL/6J tlr4-/- mice.
Results from the first experiments revealed that in wild type
C57BL/6J mice the single lpxE, lpxF and double lpxE/F mutants,
in background B128 and X47, showed a statistically significant
colonization defect (p,0.0001) (Figure 9A and 9B). In B128,
complementation of lpxE deficient strains failed to restore the
colonization defect. However, complementation of the lpxF
deficient strain successfully restored colonization to wild type
levels (p.0.05). In X47, complementation of lpxE and lpxF
deficient strains resulted in partial recovery of the colonization
defect but still significantly different from wild type (p,0.05). Data
from both cohorts of mice at day 15 were combined to increase
significance and robustness of our analysis. The double lpxE/F
mutant in strain X47 was not included because the addition of a
chloramphenicol cassette shows a strain specific decrease in the
fitness of the bacteria in colonization experiments (unpublished
observation). Overall, lpxF deficient strains in both B128 and X47
background showed the largest defect in colonization, suggesting
LpxF activity is essential for host colonization.
A second colonization experiment was performed using B128
strains in C57BL/6J and C57BL/6J tlr4-/- mice. A 3, 15 and 45
day time course was included in this study to determine if H. pylori
strains were cleared soon after infection or if it was a gradual loss
of colonization. Wild type strain B128 colonized C57BL/6J and
C57BL/6J tlr4-/- mice equally well (p.0.05) throughout the time
course (Figure 10A). Single LpxF and double LpxE/F deficient
strains were mostly unable to colonize C57BL/6J or C57BL/6J
tlr4-/- mice mice, demonstrating a colonization defect by day 3
(Figure 10C and 10D) and no significant differences were seen
when comparing C57BL/6J and C57BL/6J tlr4-/- mice (p.0.05).
However, the LpxE deficient strain colonized well until day 45
(Figure 10B) and a significant difference was seen when comparing
C57BL/6J and C57BL/6J tlr4-/- mice (p,0.01). This suggests that
resistance to CAMPs, resulting from the dephosphorylation of
lipid A by LpxF, is important for survival within a host. The role
LpxF dependent attenuated TLR4-MD2 activation plays in the
colonization of a host cannot be determined because they are so
quickly cleared from the mouse stomach, presumably due to
CAMP sensitivity. However, LpxE deficient strains retain partial
resistance to CAMPs (Table 2), giving us the ability to compare
mTLR4-MD2 dependent colonization. Interestingly, a coloniza-
tion defect seen at day 45 using wild type mice disappears in tlr4-/-
mice. Given that the LPS from lpxE mutants shows a 10-fold
increase in activation of mTLR4-MD2 (Figure 7C), one can
speculate that dephosporylation of lipid A by LpxE results in
attenuated TLR4-MD2 activation required for long term
colonization of a host. Taken together, these findings indicate
that dephosphorylation of lipid A by LpxE and LpxF in H. pylori
plays a role in effective colonization and survival within a host.
Discussion
The primary surface component of nearly all gram-negative
bacteria is the glycolipid LPS. LPS is localized to the outer leaflet
of the outer membrane, providing an additional layer of protection
from the external environment and interfacing with the surround-
ing environment. Modification of the bioactive Kdo-lipid A
domain of LPS is a common theme among gram-negative
pathogens, most likely providing an advantage to the invading
pathogen [6]. H. pylori is a great example, producing a highly
modified form of lipid A that aids in camouflaging the bacterium
from the innate immune response of its host allowing it to set up a
life long chronic infection of the gastric mucosa.
The identification and characterization of LpxF in this work
completes the five-step enzymatic pathway by which H. pylori lipid
A is modified (Figure 2), resulting in an outer surface that is highly
resistant to CAMPs and LPS that shows attenuated TLR4-MD2
activation [19]. Given that deletion of some enzymes in this five-
step pathway (e.g. LpxE, KdoH1/2, and LpxF), result in the
complete or partial loss of ‘‘downstream’’ modifications, the order
for modification of H. pylori lipid A can now be determined
Figure 9. In vivo colonization of the lpxE, lpxF and lpxE/F mutants in strain B128 and X47 at day 15 using C57BL/6J mice. C57BL/6J mice
were infected orogastrically with the indicated strains at 26108 bacteria per mouse. Colonization rates were determined after 15 days by
enumeration of colony forming units per gram (CFU/g) of stomach. Circles represent individual mice while mean colonization levels are denoted by
horizontal bars. Circles located on the x-axis represent mice with no colonization. The single lpxE, lpxF and double lpxE/F mutants in background B128
(A) and single lpxE and lpxF mutants in background X47 (B), showed a statistically significant colonization defect when compared to wild type as
indicated by a red asterisk (p,0.0001). In B128, complementation of LpxE deficient strains failed to restore the colonization defect. However,
complementation of the LpxF deficient strain successfully restored colonization to wild type levels (p.0.05). In X47, complementation of LpxE and
LpxF deficient strains resulted in partial recovery of the colonization defect but still significantly different from wild type (p,0.05). Data from two
independent cohorts of mice at day 15 were combined to increase significance and robustness of our analysis.
doi:10.1371/journal.ppat.1002454.g009
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(Figure 2). A recent publication demonstrated that efficient ligation
of O-antigen to the core-lipid A molecule is modulated by
KdoH1/2 activity in H. pylori, suggesting that surface LPS
glycosylation is also an ordered process linked to lipid A
modification [19]. Thus, it appears that the enzymatic machinery
responsible for the maturation of LPS in H. pylori evolved a highly
ordered pathway, ensuring a single and very specific surface-
exposed LPS that is essentially invisible to its host innate immune
system. Moreover, the only known variable region of the H. pylori
LPS molecule is the O-antigen, most likely allowing for adaptation
to antigenic variation in host cell surfaces [4]. One could speculate
that lack of multiple hosts for H. pylori was the key evolutionary
pressure leading to an ordered pathway; hence, any genetic drift
resulting in changes to the lipid A structure were quickly selected
against by the host innate immune system.
CAMP resistance is important for any pathogen, especially
those that establish long-term colonization of a host and H. pylori is
an excellent example. Our research identifies the dephosphoryla-
tion of lipid A in H. pylori by LpxE and LpxF as the most important
determinant of CAMP resistance identified to date in this
organism. Furthermore, our data suggest that although both
LpxE and LpxF act synergistically to provide resistance to
CAMPs, LpxF imparts the most influence. The removal of a
Kdo core sugar by KdoH1/2 was shown to influence CAMP
resistance in previous studies, with KdoH1/2 deficient strains
having a polymyxin B MIC of between 0.5 and 1.0 mg/ml, similar
to what is seen in LpxF deficient strains [19]. This can be
attributed to the inefficient removal of the 49-phosphate group by
LpxF in KdoH1/2 deficient strains of H. pylori.
It is well documented that removal or ‘‘masking’’ of phosphate
groups is the primary feature involved in CAMP resistance in
several organisms [6]. However, the exact mechanism for
resistance is more speculative and thought to occur by reducing
the binding efficiency of these peptides. By use of a biologically
Figure 10. A comparision of in vivo colonization of the lpxE, lpxF and lpxE/F mutants in strain B128 using both C57BL/6J and C57BL/
6J tlr4-/- mice. C57BL/6J and C57BL/6J tlr4-/- mice were infected orogastrically with the indicated strains at 26108 bacteria per mouse. Colonization
rates were determined after 3,15 and 45 days by enumeration of colony forming units per gram (CFU/g) of stomach. Closed circles represent
individual C57BL/6J mice and open circles represent individual C57BL/6J tlr4-/- mice. Mean colonization levels are denoted by horizontal bars. Circles
located on the x-axis represent mice with no colonization. Wild type strain B128 colonized C57BL/6J and C57BL/6J tlr4-/- mice equally well (p.0.05)
throughout the time course (A). Single LpxF (C) and double LpxE/F (D) deficient strains were mostly unable to colonize C57BL/6J or C57BL/6J tlr4-/-
mice mice, demonstrating colonization defects by day 3 and no significant differences were seen when comparing C57BL/6J and C57BL/6J tlr4-/- mice
(p.0.05). However, the LpxE (B) deficient strain colonized well until day 45 and a significant difference was seen when comparing C57BL/6J and
C57BL/6J tlr4-/- mice (p,0.01) as indicated by an asterisk.
doi:10.1371/journal.ppat.1002454.g010
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active fluorescent PMB, our data demonstrates that membranes
composed of fully phosphorylated lipid A show an increased ability
to bind CAMPs. Moreover, the use of biologically relevant
CAMPs found at multiple locations within a human host provides
evidence that resistance to CAMPs is not only important for
survival at the site of colonization, but also during transmission of
H. pylori through the oral cavity.
LPS serves as one of the most powerful activators of the innate
immune system. Presumably, H. pylori must avoid activation of
hTLR4-MD2 to set up long-term colonization of the gastric
mucosa. Producing an LPS characterized by strikingly low
endotoxicity likely contributes to this immune deception. But
which lipid A modifications in H. pylori have the greatest impact on
attenuated hTLR4-MD2 activation? Our data suggest that
dephosphorylation of lipid A by LpxE and LpxF contributes to
the low endotoxicity of H. pylori LPS, but is not the only factor. It
should be noted that LPS prepared from the double LpxE/F
mutant, synthesizing lipid A that is bis-phosphorylated and hexa-
acylated, still shows attenuated hTLR4-MD2 activity when
compared to bis-phosphorylated hexa-acylated lipid A of LPS
prepared from E. coli K-12 stains (Figure 7), requiring high
concentrations of LPS (100 ng/ml) for in vitro activation of
hTLR4-MD2. It is likely these differences arise from the increased
length of acyl chains (16 and 18 carbons) found on H. pylori lipid A.
Additionally, our data suggest that H. pylori LPS does not activate
hTLR2 even at high concentrations of LPS, helping to clarify
some conflicting reports in the literature [42].
Previous to this work, nothing was known regarding participa-
tion of H. pylori lipid A in host colonization. This work clearly
demonstrates that dephosphoryation of H. pylori lipid A by LpxE
and LpxF is essential for efficient host colonization, with LpxF
activity being the largest determinant of bacterial survival within a
host. LpxF deficient strains are unable to colonize host and are
quickly cleared within 3 days of inoculation (Figure 10A and 10B),
presumably due to loss of CAMP resistance (Table 2). However,
LpxE deficient strains retain partial resistance to CAMPs (Table 2)
and show longer-term survival within a murine model but are
cleared in a mTLR4-MD2 dependent manner by day 45
(Figure 10B). Given that LPS isolated from LpxE deficient strains
show a 10-fold increase in mTLR4-MD2 activation (Figure 7B),
mTLR4-MD2 dependent clearance from the murine stomach
seems likely. Furthermore, considering the 10-fold increase in
hTLR4-MD2 seen with LPS purified from LpxF deficient strains,
an even greater role in immune evasion within the human
stomach is suggested and highlights the importance of lipid A
modification in the pathogenesis of H. pylori.
To date, all LpxF enzymes identified only catalyze the removal
of the 49-phosphate group from penta-acylated forms of lipid A
[31,45]. H. pylori LpxF differs in that it can dephosphorylate hexa-
acylated forms of lipid A (Figure 3). The use of H. pylori LpxF for
the synthesis of 49-monophosphoryl lipid A variants could prove
useful in the development of vaccine adjuvants. Lipid A derivatives
that lack the 1-phosphate group can be prepared by chemical
synthesis, acid hydrolysis of LPS, or LpxE phosphatase treatment
and are referred to as 1-monophosphoryl lipid A [46,47,48,49].
More recently, some 49-monophosphoryl lipid A variants have
been approved as adjuvants for use in human vaccines. These lipid
A variants retain full adjuvant activity while demonstrating low
endotoxicity [50,51].
In this research, we identify the enzyme responsible for lipid A
49-phosphatase activity as Jhp1487 (LpxF) in H. pylori. We also
demonstrate that dephosphorylation of lipid A by LpxE and LpxF
in H. pylori provides resistance to CAMPs and results in attenuated
hTLR4-MD2 activation, with LpxF having the largest impact in
both cases. Removal of phosphate groups from the lipid A
backbone is essential for colonization of H. pylori in a mammalian
host. This research highlights the importance of membrane lipid
composition in the pathogenesis of gram negative bacteria and




This study was carried out in strict accordance with the
European Union Directive 2010/63/EU (and its revision 86/609/
EEC) on the protection of animals used for scientific purposes.
Our laboratory has the administrative authorization for animal
experimentation (Permit Number 75–1250) and the protocol was
approved by the Institut Pasteur Review Board that is part of in
the Regional Committee of Ethics of Animal Experiments of Paris
region (Permit Number: 99–174).
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in the study are
summarized in Table 3. Cultures of H. pylori were started from
methyl-cellulose stocks routinely stored at 280uC, plated onto 5%
sheep blood agar medium (BAP) and incubated at 37uC for 36 to
60 h in a microaerobic atmosphere (5% O2, 10% CO2, 85% N2).
The methyl-cellulose storage media is composed of cellulose-
methyl ether 4000 CPS grade (1.0% w/v) and MgSO4 (0.1 M)
and the BAP is composed of Tryptic soy agar (acumedia Cat.
7100A) and defibrinated sheep blood (Remel Cat. R54020).
Liquid cultures of H. pylori were started from overnight culture on
BAP and inoculated into brucella broth supplemented with 7%
fetal bovine serum (Hyclone) and vancomycin (10 mg/ml). Liquid
cultures of H. pylori were grown to an A600 of ,1.0 at 37uC under
microaerobic conditions for 24 to 36 h with shaking. E. coli was
routinely grown at 37uC in LB broth with appropriate antibiotics
using standard conditions.
Recombinant DNA Techniques
Plasmids were isolated using a QIAprep Spin Miniprep Kit
(Qiagen). Custom primers (Table S1 in Text S1) were obtained from
Integrated DNA Technologies. PCR reagents were purchased from
Stratagene. PCR clean up was performed using a Qiaquick PCR
Purification Kit (Qiagen). DNA fragments were isolated from
agarose gels using a Qiaquick Gel Extraction Kit (Qiagen).
Restriction endonucleases, T4 DNA ligase, and antarctic phospha-
tase were purchased from New England Biolabs. All modifying
enzymes were used according to the manufacturer’s instructions.
Construction of H. pylori Mutants
To construct the lipid A 49-phosphatase mutant, plasmid
pILL570 containing hp1580 (lpxF), from H. pylori 26695 was
obtained from a previously published library [52]. This plasmid
was reverse amplified using primers 5 and 6 (Table S1 in Text S1),
incorporating BamH1 and Kpn1 restriction sites and leaving 300
bps at the 59 and 39 end of the gene. A non-polar kanamycin
cassette was digested out of plasmid pUC18-Km2 [53] using
BamH1 and Kpn1 and ligated into the reverse PCR product in the
same orientation as hp1580 using standard cloning techniques.
The generated plasmid, pILLhp1580:kan, was used to create 49-
phosphatase defective mutants in H. pylori J99, B128 and X47 by
natural transformation [54]. Resistant colonies were selected on
blood agar plates containing 8 mg/ml of kanamycin, patched onto
kanamycin-containing plates, and verified by PCR of genomic
DNA. Gene hp1580 corresponds to jhp1487 in H. pylori J99.
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Mutation of jhp0019 (lpxE) and jhp0634 (lpxR) in H. pylori B128 and
X47 was achieved by introduction of a chloramphenicol or
kanamycin cassette into the coding sequence of each gene resulting
in the interruption and removal of a large portion of its sequence,
using previously described suicide vectors [17,22]. The lpxE/F
double mutant was created by introduction of the lpxE mutation
into a lpxF defective mutant background using natural transfor-
mation as described above.
Chromosomal Complementation of H. pylori lpxE and
lpxF Defective Mutants
The interruption of hp0954 (rdxA) renders H. pylori resistant to
metronidazole making it an ideal candidate for chromosomal
complementation [55]. Using methods previously described [22],
lpxE and lpxF defective mutants were complemented by insertion
and consequent disruption of rdxA. Briefly, the lpxE and lpxF genes
plus 500 bps upstream were amplified by PCR (primers 3,4 and
primers 1,2, respectively), Table S1 in Text S1, from H. pylori J99
genomic DNA using Pfu Turbo (Stratagene) according to the
manufacturer’s instructions. The lpxE and lpxF amplicons were
digested with BamH1 and EcoR1, gel purified, and subsequently
ligated into the previously described H. pylori rdxA complementa-
tion plasmid pET634comp [22]. Previous to ligation, plasmid
pET634comp was digested with BamH1 and EcoR1, gel purified,
and treated with antarctic phosphatase. The resulting plasmids
pETjhp1487comp and pETjhp0019comp were transformed into
H. pylori J99 lpxE and lpxF deficient mutants by natural
transformation [54]. The same method was used for complemen-
Table 3. Bacterial strains and plasmids used In this study.
Strain Genotype or descriptiona Reference
E. coli
XL-1 Blue General Cloning Strain, recA1 endA1 gyrA96thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacIqZM15::Tn10], TetR Stratagene
H. pylori
J99 Wild Type ATCC700824
B128 Wild Type [23]
X47 Wild Type [24]
J99 lpxF J99 with kanamycin resistance cassette in jhp1487, KanR This study
J99 lpxF, lpxF+ J99 lpxF with jhp1487 in rdxA, KanR, MetR This study
J99 lpxE J99 with chloramphenicol resistance cassette in jhp0019, CamR [16]
J99 lpxE, lpxE+ J99 lpxE with jhp0019 in rdxA, CamR, MetR This study
J99 lpxE/F J99 lpxF with chloramphenicol resistance cassette in jhp0019, KanR, CamR This study
J99 lpxR J99 with chloramphenicol resistance cassette in jhp0634, CamR [21]
B128 lpxF B128 with kanamycin resistance cassette in jhp1487, KanR This study
B128 lpxF, lpxF+ B128 lpxF with jhp1487 in rdxA, KanR, MetR This study
B128 lpxE B128 with chloramphenicol resistance cassette in jhp0019, CamR This study
B128 lpxE, lpxE+ B128 lpxE with jhp0019 in rdxA, CamR, MetR This study
B128 lpxE/F B128 lpxF with chloramphenicol resistance cassette in jhp0019, KanR, CamR This study
X47 lpxF X47 with kanamycin resistance cassette in jhp1487, KanR This study
X47 lpxF, lpxF+ X47 lpxF with jhp1487 in rdxA, KanR, MetR This study
X47lpxE X47 with chloramphenicol resistance cassette in jhp0019, CamR This study
X47 lpxE, lpxE+ X47 lpxE with jhp0019 in rdxA, CamR, MetR This study
X47lpxEK X47 with kanamycin resistance cassette in jhp0019, Kan
R This study
X47 lpxEK, lpxE
+ X47 lpxE with jhp0019 in rdxA, KanR, MetR This study
X47 lpxE/F X47 lpxF with chloramphenicol resistance cassette in jhp0019, KanR, CamR This study
Plasmids
pBluescript II SK(+) High-copy Cloning Vector, AmpR Stratagene
pET21a High-copy Cloning vecotor containing a T7 promoter, AmpR Novagen
piLLhp1580:kan piLL570 with hp1580 interrupted with kanamycin resistance cassette, SpecR This study
pET634comp pET21a with jhp0634 inserted into hp0954, AmpR [21]
pETjhp1487comp pEThp0954 with jhp1487 inserted into hp0954, AmpR This study
pETjhp0019comp pEThp0954 with jhp0019 inserted into hp0954, AmpR This study
pUC18-Km2 pUC18 containing a kanamycin resistance cassette from H. pylori, AmpR [53]
piLLhp1580 piLL570 with DNA fragment containing hp1580, SpecR [52]
aAntibiotics were used at the following concentrations:
For E. coli cultures, 100 mg/ml ampicillin (AmpR), 100 mg/ml spectinomycin (SpecR). For H. pylori cultures, 8 mg/ml chloramphenicol (CamR), 8 mg/ml kanamycin (KanR),
and 10 mg/ml metronidazole (MetR).
doi:10.1371/journal.ppat.1002454.t003
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tation in X47 and B128 backgrounds. Resistant colonies were
selected on blood agar plates containing 12 mg/ml metronidazole,
patched onto metronidazole-containing plates, and verified by
PCR of genomic DNA.
Isolation and Analysis of Lipid A Species from 32Pi-
Labelled Cells
H. pylori (25 ml) and E. coli (5 ml) cultures were grown in the
presence of 5.0 mCi/ml 32Pi (PerkinElmer) to an A600 of ,1.0
using standard liquid growing conditions described above and the
cells harvested by centrifugation. 32P-labelled lipid A and
phospholipids were isolated using published protocols [20] and
spotted onto a Silica Gel 60 TLC plate (EMD) at 2500 cpm/lane.
Lipid species were separated using the solvent chloroform,
pyridine, 88% formic acid and water (50:50:16:5, v/v). The
TLC plates were exposed overnight to a phosphorimager screen
and visualized using a Bio-Rad Molecular Imager phosphorimager
equipped with Quantity One software.
Isolation of Lipid A for Mass Spectrometry Analysis
H. pylori cultures (25 ml) were grown to an A600 of ,1.0 using
standard liquid growing conditions described above and the cells
harvested by centrifugation. Lipid A was purified from bacteria as
described previously [20] and stored frozen at 220 uC. The lipid
A species were analyzed using a MALDI-TOF (ABI Voyager-DE
PRO) mass spectrometer equipped with a N2 laser (337 nm) using
a 20 Hz firing rate. The spectra were acquired in negative ion
reflectron mode and each spectrum represented the average of a
minimum of 4000 shots. The matrix used was a saturated solution
of 6-aza-2-thiothymine in 50% acetonitrile and 10% tribasic
ammonium citrate (9:1, v/v). The samples were dissolved in
chloroform-methanol (4:1, v/v) and deposited on the sample plate,
followed by an equal portion of matrix solution (0.3 ml).
Preparation of Cell-free Extracts, Double-spun Cytosol,
and Washed Membrane
H. pylori cultures (200 ml) were harvested at A600 of ,1.0 and
the cells harvested by centrifugation. Cell free extracts, membrane-
free cytosol, and washed membranes were prepared as previously
described [19] and were stored in aliquots at 220uC. Protein
concentration was determined by the bicinchoninic acid method
[56].
Assay of the 49-phosphatase Activity
The 49-phosphatase activity of Jhp1487 (LpxF) was assayed
under optimized conditions in a 10- ml reaction mixture
containing 50 mM MES, pH 6.0, 0.2% Triton X-100, and
Kdo2-[49-
32P]lipid A (at ,3000–5000 cpm/nmol) as the substrate.
Kdo2-[49-
32P]lipid A was prepared as previously described [21].
Washed membranes (1.0 mg/ml) were employed as the enzyme
source. The dephosphorylation reaction was allowed to proceed at
30 uC for 3.0 h. Enzymatic reactions were terminated by spotting
4.5 ml of the mixtures on Silica Gel 60 TLC plates and the plate
was dried under a cool air stream for 20 min. Reaction products
were separated using the solvent chloroform, pyridine, 88% formic
acid, water (30:70:16:10, v/v). Reaction products were detected
and analyzed using a Bio-Rad Molecular Imager PhosphorImager
equipped with Quantity One Software.
Fluorescent Polymyxin B Binding Assay
Liquid cultures of H. pylori were grown to an A600 of ,0.8 to 1.0
at 37uC under microaerobic conditions for 24 to 36 h. The cells
were washed with PBS (3X) followed by dilution to A600 of 0.05 in
PBS. Polymyxin B Oregon Green 514 conjugate (Invitrogen) was
added to 50 ml diluted cells at select concentrations and incubated
at 37uC for 10 minutes. Following the incubation cells were
washed with PBS (3X), resuspended in 50 ml of PBS, 15 ml placed
onto poly-L-lysine coated slides (Electron Microscopy Sciences),
and coverslips added. Bacteria were viewed at a magnification of
1000X with a Nikon Eclipse 80i microscope equipped with a 100x
1.4NA PLAN APO lens, a GFP band pass emission filter set with a
480615 nm excitation range, a 535620 nm emission range and a
Photometrics Cool SNAP HQ2 camera. NIS-Elements AR 3.0
software was used to capture and create the merged images. To
quantify PMB-OG binding, strains were cultured and stained as
described above but in a volume of 200 ml. After washing, the cells
were resuspended in PBS and placed into 96-well plates for
analysis. Fluorescence (480 nm excitation and 535 nm emission)
and A600 of each well was determined using a Synergy Mx multi-
mode microplate reader (BioTek). Each experiment was repeated
in triplicate and data reported as a ratio of Fluorescence intensity
to A600. The results of three experiments were pooled and a one
tailed Mann–Whitney test was used to determine statistical
significance of observed differences (GraphPad Prism v5.0;
GraphPad Software, CA).
LPS Preparation
LPS from H. pylori was isolated from a 500 ml liquid culture
grown under standard conditions to an A600 of ,1.0 using the hot
water-phenol method [57]. Isolated LPS was further purified to
remove contaminating immuno-stimulatory proteins (e.g. lipopro-
teins) that could falsely alter TLR assays using the previously
described Hirschfeld method [39]. Purified LPS was quantified
using a Mettler Toledo XS105 Dual Range analytical balance
(sensitivity$0.1 ng) and resuspended in HyPure Cell Culture
Grade Endotoxin Free Water (HyClone) to a concentration of
5 mg/ml.
Determination of Minimum Inhibitory Concentrations
(MIC)
MIC determination using Polymyxin B Etest strips (Biomérieux)
was determined as previously described [19]. For MIC determi-
nation in liquid medium, the Hancock Laboratory Microtiter
Broth Dilution Method was used and modified as needed [58]. H.
pylori strains were grown overnight in brucella broth supplemented
with 7% fetal bovine serum. The overnight cultures were
inoculated into a 96-well microtiter plates at a starting A600 of
0.05, in a total volume of 100 ml standard H. pylori growing
medium, supplemented with select concentration of CAMPs. The
96-well plates were incubated at 37uC in a microaerobic
atmosphere (5% O2, 10% 1 CO2, and 85% N2) with constant
shaking and A600 of each well determined using a Synergy-Mx
monochromator based multi-mode microplate reader at 24 and
48 hours. Each experiment was repeated in triplicate. A positive
growth control containing no CAMP and a negative control
containing no bacteria was performed with every replicate. The
MIC was taken as the lowest concentration of CAMP that reduced
growth (A600) by more than 50% when compared to the positive
growth control. The following CAMPs were purchased and used
in the MIC experiment: polymyxin B (Sigma), human b defensin-2
(Phoenix Pharm), human cathelicidin LL-37 (Anaspec), histatin-5
P-113 (Sigma), human neutrophil peptide-2 (Bachem), and H.
pylori peptide HP2-20 (Invitrogen). All peptides were stored
according to manufacturers’ instructions. Because of cost, MICs
were only determined for mutants in the J99 background.
Complemented strains were also excluded.
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TLR Signaling Assay
For TLR4 and TLR2, human epithelial kidney (HEK) 293 cells
stably co-transfected with m or hTLR4, m or hMD2, and m or
hCD14 (denoted as HEK-m/hTLR4) or m/hTLR2 and m/
hCD14 (denoted as HEK-m/hTLR2) were purchased from
InvivoGen (CAT. hkb-htlr4 and hkb-htlr2 or hkb-mtlr4 and
hkb-mtlr2, respectively). All cell lines stably express secreted
embryonic alkaline phosphatase (SEAP) under the control of a
promoter inducible by NF-kB and activator protein 1 (AP-1).
Thus, stimulation of m/hTLR4-MD2 or m/hTLR2 will result in
an amount of extracellular SEAP in the supernatant that is
proportional to the level of NF-kB induction. The cell lines were
maintained in standard Dulbecco’s modified Eagle’s medium
(DMEM) with 10% heat-inactivated fetal bovine serum (FBS)
(Gibco) supplemented with 4.5 g/L glucose, 2 mM L-glutamine,
50 U/mL penicillin, 50 ug/ml streptomycin and 1X HEK-Blue
selection (InvivoGen) in a 5% saturated CO2 atmosphere at 37uC.
The induction of TLR signaling in HEK-m/hTLR4 and HEK-
m/hTLR2 cell lines was assessed by measuring SEAP activity
using QUANTI-BlueTM colorimetric assay (InvivoGen). The assay
was performed according to manufacturer’s protocols. Briefly, cells
were seeded in a 96-well plate in triplicate (2.56104 cells/well for
HEK-m/hTLR4 and 56104 cells/well for HEK-m/hTLR2) in
the presence or absence of 10-fold dilutions of purified LPS.
Controls included Rhodobacter sphaeroides LPS (TLR4 antagonist)
(InvivoGen), E. coli W3110 LPS (TLR4 agonist) and the synthetic
triacylated lipoprotein Pam3CSK4 (TLR2 agonist) (InvivoGen).
After 20–24 h incubation, supernatants (20 ul) were transferred to
a 96-well plate and incubated at 37uC with QUANTI-Blue
(180 ul) for 1-2. SEAP activity was measured by reading optical
density at 655 nm with a Synergy Mx multi-mode microplate
reader (BioTek). The results of several (at least three) experiments
were pooled and a one tailed Mann–Whitney test was used to
determine statistical significance of observed differences (Graph-
Pad Prism v5.0; GraphPad Software, CA).
Mouse Colonization Assays
C57BL/6J female mice purchased from Charles River Labo-
ratories and C57BL/6J tlr4 -/- female mice from Pasteur Institute
(kindly provided by Shizuo Akira) aged 4 to 5 weeks were infected
orogastrically with feeding needles with either X47 or B128 strains
(26108 bacteria per mouse). Colonization rates were determined
after 3, 15 or 45 days by enumeration of colony forming units
(CFU) per gram of stomach. Mice were euthanized with CO2 and
the stomachs were ground and homogenized in peptone broth.
The samples were then diluted and spread on blood agar plates
supplemented with 200 mg/ml of bacitracin, and 10 mg/ml of
nalidixic acid, to inhibit the growth of resident bacteria from the
mouse forestomach. The CFUs were enumerated after 8 days of
incubation under microaerobic conditions. The results of several
(at least two) colonization experiments were pooled and a one
tailed Mann–Whitney test was used to determine statistical
significance of observed differences (GraphPad Prism v5.0;
GraphPad Software, CA).
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